MedTrace Logo

The Effect of Sevofluorane on Wash-out Time in COPD

NCT02209883 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 60

Last updated 2015-08-06

No results posted yet for this study

Summary

COPD (Chronic obstructive disease ) is a condition of respiratory system failure seen occasionally in elderly patients of society. Sevofluorane is a safe, volatile anesthetic used considerably widely all over the world. Because respiratory functions and gas exchange became impaired in COPD patients, the respiratory system excretion/washout of inhalational anesthetic agents can be affected. In our study we aimed to investigate if there is a relation between sevofluorane's washout time and the degree of COPD.

Conditions

  • Anesthesia

Sponsors & Collaborators

  • Duzce University

    lead OTHER

Principal Investigators

  • Ilknur Suidiye Seker, Asist. prof. · Duzce University School of Medicine

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-11-30
Primary Completion
2015-08-31
Completion
2015-08-31

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02209883 on ClinicalTrials.gov